Bengt Gustavsson, MD, Ph.D, Prof. is the founder of Isofol Medical and was the head of surgical oncology at Sahlgrenska University Hospital, Gothenburg, Sweden. He co-discovered the positive effects of leucovorin on 5-FU that created the widely used combination treatment against colorectal cancer.
Bengt Gustavsson has been a member of the scientific committee of the Swedish Cancer Society since 1996, and has been a member of its scientific committee for two terms. He is a member of the American Society of Clinical Oncology, European Surgical Society, Swedish Surgical Society and the Swedish Society of Colon and Rectal Surgeons.
Yield life Science AB
For more information on Yield Life Science please visit www.yield.nu